Workflow
Earnings estimate revisions
icon
Search documents
Palantir Technologies Inc. (PLTR) Boasts Earnings & Price Momentum: Should You Buy?
ZACKS· 2025-09-29 14:30
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.The Zacks Premium service makes this easier. It features daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter. All of these can help you quickly identify what stocks to buy, what to sell, and what are today's hottest ...
First Northwest Bancorp (FNWB) Soars 5.0%: Is Further Upside Left in the Stock?
ZACKS· 2025-09-29 13:05
First Northwest Bancorp (FNWB) shares soared 5% in the last trading session to close at $7.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 4.2% loss over the past four weeks.With the Federal Reserve starting an interest rate cut cycle and hinting at two more rate cuts this year, banking stocks are in the spotlight. As rates come down, banks' funding/deposit costs are expected to stabilize and the lending scenario is likely to ...
Electronic Arts (EA) Soars 14.9%: Is Further Upside Left in the Stock?
ZACKS· 2025-09-29 10:06
Electronic Arts (EA) shares rallied 14.9% in the last trading session to close at $193.35. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 1.6% loss over the past four weeks.The upswing came after The Wall Street Journal reported that Electronic Arts could be acquired by a group of private equity firms.This video game maker is expected to post quarterly earnings of $1.29 per share in its upcoming report, whic ...
GlobalFoundries (GFS) Surges 8.4%: Is This an Indication of Further Gains?
ZACKS· 2025-09-29 10:06
GlobalFoundries Inc. (GFS) shares rallied 8.4% in the last trading session to close at $35.59. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 2.2% loss over the past four weeks.The upswing came after the Wall Street Journal reported that the President Donald Trump administration is working on a proposal to mandate semiconductor companies to build chips in America over time to meet the entire domestic demand. ...
Palo Alto Networks (NASDAQ:PANW): A Leader in Cybersecurity
Financial Modeling Prep· 2025-09-27 22:00
Palo Alto Networks (NASDAQ:PANW) is a leading cybersecurity company known for its advanced security solutions. The company provides a range of products and services designed to protect organizations from cyber threats. As a key player in the cybersecurity industry, Palo Alto Networks competes with other major firms like Fortinet and Check Point Software Technologies.On September 26, 2025, an analyst from UBS set a price target of $245 for PANW. At that time, the stock was trading at $201.99, suggesting a po ...
Ekso Bionics (EKSO) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-09-26 17:00
Ekso Bionics (EKSO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The power o ...
Here's Why Daktronics (DAKT) Is a Great 'Buy the Bottom' Stock Now
ZACKS· 2025-09-26 14:56
Shares of Daktronics (DAKT) have been struggling lately and have lost 7.2% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future earning ...
Here's Why Qorvo (QRVO) is a Strong Value Stock
ZACKS· 2025-09-26 14:40
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are t ...
Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI
ZACKS· 2025-09-26 00:21
Core Insights - Collegium Pharmaceutical (COLL) and Masimo Corporation (MASI) are highlighted as strong buy stocks due to rising earnings estimate revisions and their respective market positions in the medical sector [1][2]. Collegium Pharmaceutical (COLL) - Collegium is recognized as an undervalued specialty pharmaceutical company focusing on central nervous system, respiratory, and skin-related disorders [1]. - The company is projected to achieve a 20% increase in revenue and a 9% increase in earnings this year, with low-single digit growth expected for fiscal 2026 [3]. - Collegium's stock is trading at a forward earnings multiple of 5X and a sales multiple of less than 2X, significantly below the S&P 500 averages and the Zacks Medical-Drugs Industry average of 15.5X forward earnings and 3.4X forward sales [4]. - EPS projections for Collegium have risen to over $7 per share, distinguishing it from over 130 smaller-cap pharmaceutical companies that are currently unprofitable [5]. Masimo Corporation (MASI) - Masimo is noted for its non-invasive health monitoring systems, which provide real-time insights into patient physiology [2]. - The company is expected to see a 20% increase in annual earnings for FY25, reaching $5.30 per share, up from $4.40 last year, with a further 7% increase projected for FY26 [7]. - Masimo's stock trades at a forward earnings multiple of 26.5X, slightly above the Zacks Medical-Instruments Industry average of 23.5X, indicating a justified premium due to its growth prospects [7]. Market Context - Both Collegium and Masimo have experienced significant EPS revisions over the last 60 days, making them attractive options for growth and value in a market characterized by high volatility [9].
Strength Seen in Ivanhoe Electric (IE): Can Its 7.9% Jump Turn into More Strength?
ZACKS· 2025-09-25 13:46
Core Viewpoint - Ivanhoe Electric's shares experienced a significant increase of 7.9% to close at $10.84, driven by strong trading volume and higher copper prices [1][2]. Group 1: Company Performance - Ivanhoe Electric is projected to report a quarterly loss of $0.21 per share, reflecting a year-over-year increase of 41.7%. Revenue is expected to reach $1.07 million, marking a 59.7% increase from the same quarter last year [3]. - The consensus EPS estimate for Ivanhoe Electric has remained stable over the past 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [4]. Group 2: Industry Context - The rise in Ivanhoe Electric's stock is attributed to higher copper prices, which increased by 3.77% to $4.84 per pound, following Freeport-McMoRan's declaration of force majeure at its Grasberg mine in Indonesia [2]. - Freeport-McMoRan anticipates a 4% reduction in third-quarter 2025 copper sales and a 6% decrease in gold sales due to operational disruptions [2]. - Hudbay Minerals has also temporarily suspended operations at its Constancia mine in Peru due to protests, raising supply concerns and further supporting price increases [2]. Group 3: Industry Comparisons - Ivanhoe Electric is part of the Zacks Mining - Miscellaneous industry, where Nexa Resources S.A. also operates. Nexa's shares increased by 1.2% to $5.04, with a 1.8% return over the past month [5]. - Nexa Resources' consensus EPS estimate has risen by 25% over the past month to $0.1, representing a 400% increase compared to the previous year's EPS [6].